Missing/wrong data?
Log in to edit
A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma
scientific article published on 17 June 2013
Author/s
author: Anna K. Nowak, Chris Brown, Michael J. Boyer, Jenette Creaney
Work details
Publication date
June 17, 2013
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.